Share

Mission: To develop and offer the highest impact neurological research.
Vision: To be a world-class leader for innovative neurological research.



We are actively enrolling in clinical research trials -- call (904)834-3007 for more information and updates.


  1. RRMS Disease Modifying Agent: Pegylated interferon -- ADVANCE

  2. RRMS Disease Modifying Agent: Ocrelizumab vs. Rebif -- OPERA

  3. RRMS Disease Modifying Agent: Tysabri -- TOPPLE

  4. RRMS Disease Modifying Agent: Gilenya (fingolimod) vs. other disease modifying agents -- EPOC

  5. MS Gait (walking): Lower dose Ampyra (dalfampridine) -- DER-401

  6. MS Tremor -- Deep Brain Stimulation Surgery

  7. Blood test looking for JC virus antibody in MS patients -- STRATIFY-2

  8. UCSF MS Genetic Susceptibility Project -- one time blood draw for all MS patients

  9. Questionnaire for people with MS, Parkinson's, Stroke, Alzheimer's dementia, ALS (Amyotrophic Lateral Sclerosis or Lou Gherig's disease), or TBI (Traumatic Brain Injury) -- Prism Registry



The following trials have completed enrollment:


  1. Chronic Migraine: Topamax vs. Topamax + Propranolol LA -- CMTT

  2. RRMS Disease Modifying Agent: Less frequent Copaxone -- GALA

  3. MS Relapses: ACTH vs. Solumedrol -- RECLAIM


Neurologique Foundation, Inc.: Improving neurologic patient care, education and research. - info@neurologique.org

All Content Copyright © 2010 Neurologique Foundation Inc., All Rights Reserved